Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Yider Bio-technology is a specialized biotechnology company headquartered in Qingdao, China, focusing on the development and manufacture of in vitro diagnostic (IVD) products. The company provides a wide range of diagnostic solutions, including rapid test kits based on colloidal gold and fluorescence immunochromatography technologies, as well as various biochemical reagents. Their product portfolio primarily targets infectious diseases, cardiac markers, inflammation, and gastric health, with notable contributions to respiratory virus testing. Operating from a GMP-certified facility, Yider Bio-technology serves clinical laboratories and healthcare providers both domestically and internationally. The company is committed to delivering high-sensitivity, user-friendly diagnostic tools to improve patient outcomes and public health monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Yider Bio-technology.